Clifford Quan

Title: The Innovations of Clifford Quan

Introduction

Clifford Quan is a notable inventor based in Belmont, California. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target specific proteins involved in various disorders. His work has the potential to impact the treatment of diseases mediated by Fibroblast Activation Protein (FAP).

Latest Patents

Clifford Quan holds a patent for "Fibroblast activation protein inhibitor compounds and methods." This patent describes amino terminus-blocked peptide boronate compounds that are useful for inhibiting FAP and other proteases. The methods outlined in the patent detail the use of these compounds for the diagnosis, prevention, or treatment of disorders in mammalian cells, as well as associated pathological conditions.

Career Highlights

Currently, Clifford Quan is employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biomedical research.

Collaborations

Some of his notable coworkers include Frederick Cohen and Wayne J Fairbrother. Their collaborative efforts have likely contributed to the advancement of research and development in their respective areas of expertise.

Conclusion

Clifford Quan's innovative work in developing FAP inhibitor compounds showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of various disorders.